Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis

Journal of Experimental Medicine

Volumn 190, Issue 4, 1999, Pages 535-542

  Song, Xiao Yu ^a   Zeng, Li ^a   Jin, Wenwen ^a   Thompson, John ^a   Mizel, Diane E ^a   Lei, Ke Jian ^a   Billinghurst, R C ^b   Poole, A Robin ^b   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cartilage resorption; Inflammation; Serine protease inhibitor

Indexed keywords

COLLAGEN TYPE 2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTHRITIS; ARTHROPATHY; ARTICLE; BACTERIAL CELL WALL; BONE DESTRUCTION; CARTILAGE DEGENERATION; CHONDROLYSIS; CONTROLLED STUDY; DNA SEQUENCE; DRUG SCREENING; FEMALE; INFLAMMATION; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS; BASE SEQUENCE; CELL WALL; CLONING, MOLECULAR; EXTREMITIES; FEMALE; INFLAMMATION MEDIATORS; JOINTS; MOLECULAR SEQUENCE DATA; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; SERINE PROTEINASE INHIBITORS; STREPTOCOCCUS PYOGENES;

EID: 0033575758     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.4.535     Document Type: Article

References (45)

1. Weiss, S.J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376.
2. Henson, P.M., and R.B. Johnston, Jr. 1987. Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J. Clin. Invest. 79:669-674.
3. Poole, A.R., M. Alini, and A.P. Hollander. 1995. Cellular biology of cartilage degradation. In Mechanisms and Models in Rheumatoid Arthritis. B. Henderson, R. Pettifer, and J. Edwards, editors. Academic Press Ltd., London. 163-204.
4. Barrett, A. 1978. The possible role of neutrophil proteinases in damage to articular cartilage. Agents Actions. 8:11-18.
5. Wilhelm, S.M., D. Wunderlich, C.A. Maniglia, A.Z. Eisen, and G.I. Goldberg. 1992. Primary structure and function of stromelysin/transin in cartilage matrix turnover. In Matrix Metalloproteinases and Inhibitors. H. Birkedal-Hansen, Z. Werb, H. Welgus, and H. Van Wart, editors. Gustav Fischer Verlag, Stuttgart, Germany. 37-44.
6. Ghosh, P., and D. Burkhardt. 1991. The latent serine proteinases of normal and degenerate (OA) human cartilage. Trans. Orthop. Res. Soc. 16:198.
7. Dean, D.D. 1991. Proteinase mediated cartilage degradation in osteoarthritis. Semin. Arthritis Rheum. 20:2-11.
8. McDonald, J.A., and D.G. Kelley. 1980. Degradation of fibronectin by human leukocyte elastase. J. Biol. Chem. 255: 8848-8858.
9. Kafienah, W., D.J. Buttle, D. Burnett, and A.P. Hollander. 1998. Cleavage of type I collagen by human neutrophil elastase. Biochem. J. 330:897-902.
10. Bohm, B., R. Deutzmann, and H. Burkhardt. 1991. Purification of a serine protease inhibitor from human cartilage. Biochem. J. 274:269-273.
11. Andrews, J.L., J. Melrose, and P. Ghosh. 1992. A comparison of serine proteinase inhibitors of human connective tissues. Biol. Chem. Hoppe-Seyler. 373:111-118.
12. McElvaney, N.G., and R.G. Crystal. 1997. Antiproteases and lung defense. In The Lung: Scientific Foundations. Vol. 2. R.G. Crystal, J.B. West, E.R. Weibel, and P.J. Barnes, editors. Lippincott-Raven, Inc., New York. 2219-2236.
13. Thompson, R.C., and K. Ohlsson. 1986. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA. 83:6692-6696.
14. Fritz, H. 1988. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor 1 (HUSI-1), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol. Chem. Hoppe-Seyler. 369(Suppl.):79-82.
15. Hutchison, D.C. 1987. The role of proteases and antiproteases in bronchial secretions. Eur. J. Respir. Dis. Suppl. 153:78-85.
16. Franken, C.J., L.M. Meijer, and J.H. Dijkman. 1989. Tissue distribution of antileukoprotease and lysozyme in humans. J. Histochem. Cytochem. 37:493-498.
17. Eisenberg, S.O., K.K. Hale, P. Heimdal, and R.C. Thompson. 1990. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J. Biol. Chem. 265:7976-7981.
18. McNeely, T.B., M. Dealy, D.J. Dripps, J.M. Orenstein, S.P. Eisenberg, and S.M. Wahl. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-HIV-1 activity in vitro. J. Clin. Invest. 96:454-464.
19. Heimstra, P.S., R.J. Massen, J. Stolk, R.W. Heinzel, G. Steffens, and J.H. Dijkman. 1996. Antibacterial activity of antileukoprotease. Infect. Immun. 64:4520-4524.
20. McNeely, T.B., D.C. Shugars, M. Rosendahl, C. Tucker, S.P. Eisenberg, and S.M. Wahl. 1997. Inhibition of human immunodeficiency virus type I infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood. 90:1141-1149.
21. Wahl, S.M., X-y. Song, W.W. Jin, and K.-J. Lei. 1998. Secretory leukocyte protease inhibitor (SLPI), not just a protease inhibitor. In Oral Biology at the Turn of the Century: Misconceptions, Truths, Challenges and Prospects. Karger, Basel, Switzerland. 211-216.
22. Jin, F.-Y., C. Nathan, D. Radzioch, and A. Ding. 1997. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell. 88:417-426.
23. Zitnik, R.J., J. Zhang, M.A. Kashem, T. Kohno, D.E. Lyons, C.D. Wright, E. Rosen, I. Goldberg, and A.C. Hayday. 1997. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA. Biochem. Biophys. Res. Commun. 232:687-697.
24. Jin, F.Y., C.F. Nathan, D. Radzioch, and A.H. Ding. 1998. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect. Immun. 66:2447-2452.
25. Song, X.-y., M.-L. Gu, W.W. Jin, D.M. Klinman, and S.M. Wahl. 1998. Plasmid DNA encoding transforming growth factor-β1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J. Clin. Invest. 101:2615-2621.
26. Kramps, J.A., C. van Twisk, and A.C. van der Linden. 1983. L-pyroglutamyl-L-prolyl-L-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase. Scand. J. Clin. Lab. Invest. 43:427-432.
27. Somorin, O., S. Tokura, N. Nishi, and J. Noguchi. 1979. The action of trypsin on synthetic chromogenic arginine substrates. J. Biochem. 85:157-162.
28. DelMar, E.G., C. Largman, J.W. Brodrick, and M.C. Geokas. 1979. A sensitive new substrate for chymotrypsin. Anal. Biochem. 99:316-320.
29. Groutas, W.C., M.J. Brubaker, R. Venkataraman, J.B. Epp, M.A. Stanga, and J.J. McClenahan. 1992. Inhibitors of human neutrophil cathepsin G: structural and biochemical studies. Arch. Biochem. Biophys. 294:144-146.
30. McCartney-Francis, N.L., X.-y. Song, D.E. Mizel, C.L. Wahl, and S.M. Wahl. 1999. Hemoglobin protects from streptococcal cell wall-induced arthritis. Arthritis Rheum. 42:1119-1127.
31. Billinghurst, R.C., L. Dahlberg, M. Ionescu, A. Reiner, R. Bourne, C. Rorabeck, P. Mitchell, J. Hambor, O. Diekmann, H. Tschesche, et al. 1997. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest. 99:1534-1545.
32. Sallenave, J.-M., J. Shulmann, J. Crossley, M. Jordana, and J. Gauldie. 1994. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11:733-741.
33. Chen, W.J., W.W. Jin, M. Cook, H.L. Weiner, and S.M. Wahl. 1998. Oral delivery of group A streptococcal cell walls augments circulating TGF-β and suppresses streptococcal cell wall arthritis. J. Immunol. 161:6297-6304.
34. Sankar, G., M.J. May, and E.B. Kopp. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
35. Böhm, B., T. Aigner, R. Kinne, and H. Burkhardt. 1992. The serine-protease inhibitor of cartilage matrix is not a chondrocytic gene product. Eur. J. Biochem. 207:773-779.
36. Ohlsson, S., B. Tufvesson, Å. Polling, and K. Ohlsson. 1997. Distribution of the secretory leukocyte proteinase inhibitor in human articular cartilage. Biol. Chem. 378:1055-1058.
37. Jacoby, A.S., J. Melrose, B.C. Robinson, V.J. Hyland, and P. Ghosh. 1993. Secretory leukocyte proteinase inhibitor is produced by human articular cartilage chondrocytes and intervertebral disc fibrochondrocytes. Eur. J. Biochem. 218:951-957.
38. Alini, M., Y. Matsui, G.R. Dodge, and A.R. Poole. 1992. The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen. Calcif. Tissue Int. 50:327-335.
39. Campbell, E.J., E.K. Silverman, and M.A. Campbell. 1989. Elastase and cathepsin G of human monocytes. Quantification of cellular contents, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143:2961-2968.
40. Senior, R.M., E.J. Campbell, J.A. Landis, F.R. Cox, C. Kuhn, and H.S. Koren. 1982. Elastase of U-937 monocyte-like cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophage-like cells. J. Clin. Invest. 69:384-393.
41. Tschopp, J., and C.V. Jogeneel. 1988. Cytotoxic T lymphocyte mediated cytolysis. Biochemistry. 27:2641-2646.
42. Zhang, Y., D.L. DeWitt, T.B. McNeely, S.M. Wahl, and L.M. Wahl. 1997. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J. Clin. Invest. 99:894-900.
43. Janusz, M.J., and S.L. Durham. 1997. Inhibition of cartilage degradation in rat collagen-induced arthritis but not adjuvant arthritis by the neutrophil elastase inhibitor MDL 101,146. Inflamm. Res. 46:503-508.
44. Moore, A.R., H. Iwamura, J.P. Larbre, D.L. Scott, and D.A. Willoughby. 1993. Cartilage degradation by polymorphonuclear leukocytes: in vitro assessment of the pathogenic mechanisms. Ann. Rheum. Dis. 52:27-31.
45. Lentsch, A.B., J.A. Jordan, B.J. Czermak, K.M. Diehl, E.M. Younkin, V. Sarma, P.A. Ward. 1999. Inhibition of NF-κB activation and augmentation of Iκ Bβ by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 154:239-247.